Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Bristol-Myers Squibb Company (BMY)

  • SEC News
  • Oct. 30, 2025, 11:09 UTC
  • 6
  • 1 comments

(10% Negative) BRISTOL-MYERS SQUIBB COMPANY (BMY) Reports Q4 2025 Financial Results

Comment Full text

Bicycle Therapeutics (BCYC)

  • SEC News
  • Oct. 30, 2025, 11:05 UTC
  • 6
  • 1 comments

(30% Negative) Bicycle Therapeutics plc (BCYC) Reports Q4 2025 Financial Results

Comment Full text

Eli Lilly and Company (LLY)

  • SEC News
  • Oct. 30, 2025, 11:03 UTC
  • 6
  • 1 comments

(90% Positive) ELI LILLY AND COMPANY (LLY) Reports Q4 2025 Financial Results

Comment Full text

HALEON PLC (HLN)

  • SEC News
  • Oct. 30, 2025, 11:01 UTC
  • 7
  • 1 comments

(99% Neutral) HALEON PLC (HLN) Files Form 6-K

Comment Full text

Liquidia Corporation (LQDA)

  • SEC News
  • Oct. 30, 2025, 11:00 UTC
  • 6
  • 1 comments

(99% Neutral) LIQUIDIA CORPORATION (LQDA) Announces Business Combination

Comment Full text

Insmed Inc (INSM)

  • SEC News
  • Oct. 30, 2025, 11:00 UTC
  • 2
  • 1 comments

(10% Negative) INSMED INCORPORATED (INSM) Reports Q4 2025 Financial Results

Comment Full text

Phathom Pharmaceuticals Inc (PHAT)

  • SEC News
  • Oct. 30, 2025, 11:00 UTC
  • 2
  • 1 comments

(30% Negative) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Q4 2025 Financial Results

Comment Full text

Novocure Ltd (NVCR)

  • SEC News
  • Oct. 30, 2025, 10:59 UTC
  • 4
  • 1 comments

(30% Negative) NovoCure Limited (NVCR) Reports Q4 2025 Financial Results

Comment Full text

Option Care Health Inc (OPCH)

  • SEC News
  • Oct. 30, 2025, 10:56 UTC
  • 5
  • 1 comments

(30% Negative) OPTION CARE HEALTH, INC. (OPCH) Reports Q4 2025 Financial Results

Comment Full text

Cardinal Health Inc (CAH)

  • SEC News
  • Oct. 30, 2025, 10:52 UTC
  • 5
  • 1 comments

(30% Negative) Cardinal Health, Inc. (CAH) Reports Q4 2025 Financial Results

Comment Full text
  • Previous
  • 48
  • 49
  • 50
  • 51
  • 52
  • Next

Search

News categories

  • Technical Exchange News(10321)
  • Event(1442)
  • SEC News(175319)
  • FDA Approval(9644)
  • Company Report(721)
  • Business News(117670)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin